Viewing Study NCT04898894

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:44 AM
Ignite Modification Date: 2026-05-13 @ 7:18 AM
Study NCT ID: NCT04898894
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-16
First Post: 2021-05-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
Sponsor: St. Jude Children's Research Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Leukemia of Ambiguous Lineage in Relapse View
None Acute Myeloid Leukemia, in Relapse View
None Refractory Acute Leukemia of Ambiguous Lineage View
None Refractory Acute Myeloid Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acute Myeloid Leukemia, in Relapse View
None Refractory Acute Myeloid Leukemia View
None Acute Leukemia of Ambiguous Lineage in Relapse View
None Refractory Acute Leukemia of Ambiguous Lineage View
None Pediatric View
None Young Adult View